This electronic supplementary material shows the origin of the values used in the simulations presented in the manuscript. Data representing the hospital flow of patients with severe respiratory failure were extracted from two Brazilian case series. The first is the ERICC (Epidemiology of Respiratory Insufficiency in Critical Care) study, (1) which characterized 7,465 patients admitted to 45 Brazilian intensive care units (ICU) over two months in 2011. Of these patients, 773 required mechanical ventilation for more than 72 hours, and 242 were diagnosed with acute respiratory distress syndrome. The second series was from the Hospital das Clínicas of the Faculdade de Medicina of the Universidade de São Paulo (HCFMUSP) where ten patients with extremely severe respiratory failure (who were classified as dying) received extracorporeal membrane oxygenation (ECMO), (2) resulting in a six-month survival rate of 40%. These patients did not receive dialysis or supplemental oxygen after six months of evaluation.
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The costs used in the analysis were collected from payments made by SUS for the necessary equipment over an average of three months in 2012; the analysis did not account for the costs of medical professionals. This survey was conducted by the NATS of HCFMUSP, which belongs to the Brazilian Network for Health Technology Assessment (Rede Brasileira de Avaliação de Tecnologias em Saúde; REBRATS) of the Ministry of Health. This survey has been used for other cost effectiveness analyses. Tables 1 and 2 show the events and periods of mechanical ventilation, ECMO, admittance to ICU, and so on that were also used for the Markov model probability calculations. Table 3 shows the summary of costs, which are detailed in tables 4 through 9. The details of the support days are shown in tables 10 through 20. Posteroanterior chest x-ray R$ 20.00 1 R$ 20.00
Ranitidine hydrochloride 50mg R$ 0.20 3 R$ 0.59
Disposable syringe 10mL R$ 0.18 3 R$ 0.54
Disposable syringe 20mL R$ 0.27 24 R$ 6.48
Blood gas syringe R$ 2.14 4 R$ 8.56
Tracheal care endotracheal suction system (14 gauge) R$ 33.50 1 R$ 33.50 This analysis includes all patients, including those treated with noninvasive ventilation. ECMO -extracorporeal membrane oxygenation; NIV -noninvasive ventilation; MV -mechanical ventilation; QALY -quality-adjusted life-years. 
